Direxion Daily S&P Biotech Bull 3X Shares
LABUETF · NYSE Arca
$241.18
+$12.80 (+5.60%)
EOD Nov 3, 2026
Key facts
- Dividend yield (TTM)
- 0.38%
- Distributions
- Quarterly
- Fund net assets (Jul 2026)
- $494M
- Stocks held
- 147
- Other positions
- 10
- 52-week range
- $108.90 to $341.93
Top 10 holdings
All holdings9.4% of assets in ten stocks, as of Jul 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 1.11% | n/a | |
| 1.03% | 10 | |
| 0.96% | 10 | |
| 0.93% | n/a | |
| 0.92% | 40 | |
| 0.90% | 25 | |
| 0.89% | 10 | |
| 0.89% | 10 | |
| 0.88% | 40 | |
| 0.88% | 54 |
Sector allocation
Share of the fund's assets
- Healthcare65.6%
- Industrials1.1%
- Financials0.3%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
5% of the fund's stock weight sits in companies with a Quality score above 75, 65% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States63.4%
- Ireland0.8%
- Bermuda0.8%
- Netherlands0.7%
- Switzerland0.7%
- British Virgin Islands0.4%
- Cayman Islands0.1%
- Canada0.1%
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyLABU pays quarterly. Over the last twelve months it paid $0.91 per share, a 0.38% yield at today's price. The latest payment was $0.91, ex-dividend Dec 23, 2025.
LABU questions
What does LABU invest in?+
Direxion Daily S&P Biotech Bull 3X Shares is an exchange-traded fund. Its largest holdings are Apogee Therapeutics Inc. (1.11%), Oruka Therapeutics, Inc. (1.03%), Dianthus Therapeutics Inc. (0.96%).
How much does LABU pay in dividends?+
LABU paid $0.91 per share over the last twelve months, a 0.38% yield at the Nov 3, 2026 close of $241.18. It pays quarterly.
How good are the companies LABU owns?+
Weighted by position size, the stocks in LABU average a Quality score of 35 out of 100. 5% of the fund's stock weight sits in companies scoring above 75, 65% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Jul 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to n/a. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Nov 3, 2026.